Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment MISGAV, Israel, Aug. 31, 2020 /PRNewswire/ — Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. Participating in the financing were […]
Read More